Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Tricetin
Cat. No.:
0225LY-1444
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Tricetin is a pomegranate-derived flavonoid that acts as a competitive inhibitor of the Keap1-Nrf2 interaction, protecting against neurotoxicity and inhibiting the growth and migration of nasopharyngeal carcinoma through the Akt/GSK-1β pathway.
Synonym:
520-31-0; 5,7,3',4',5'-Pentahydroxyflavone; Hieracin; 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one; 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one; 5,7,3,4,5-pentahydroxyflavone; 3',4',5,5',7-pentahydroxyflavone
CAS No.:
520-31-0
Compound CID:
5281701
Formula:
C15H10O7
Formula Weight:
302.24
Specification
Relative Density:
1.763 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Tricetin can be used in cancer biology to investigate its anti-proliferative effects and its role in inducing apoptosis in malignant cells.
Library Information
Target:
Nrf2; Keap1; HO-1
Receptor:
Nrf2; Keap1; HO-1
Pathways:
Immunology/Inflammation; Apoptosis
Plate Number:
AOCL-19
Plate Location:
e7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
22.5 mg/mL; 74.44 mM
